Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice

CR8 is a second generation inhibitor of cyclin-dependent kinases derived from roscovitine. CR8 was shown to be 50–100 fold more potent than roscovitine in inducing apoptosis in different tumor cell lines.